Biotech grants in France
Explore Biotech grants for companies in France. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from French innovation agencies, research funders and foundations, EU and international programs open to applicants in France, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in France come first.
Showing 313-336 of 637 grants
Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases
NIH · United States
Funds consortium research using multi-omics and AI on how infections cause chronic illness, and how chronic illness worsens infections.
Canine Cancer Immunotherapy Network (K9CIN)
NIH · United States
Funds a five-award network running canine cancer immunotherapy trials whose results are meant to translate directly into human cancer treatment.
Genomic Community Resources
NIH · United States
Funds new or existing genomic resources of broad value to the research community, for both basic and clinical genomics.
Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research
NIH · United States
Funds cooperative agreements pairing specific-pathogen-free animal colonies with human-based alternatives for HIV/AIDS research.
National Biomedical Research Centers
NIH · United States
Funds specialised biomedical research centers built to replace animal testing with new human-based research models.
Research Resource for a National Swine Resource and Research Center
NIH · United States
Funds the national center that breeds, preserves, genotypes and distributes genetically modified pig models for biomedical research.
Collaborative Network for Clinical Research on Immune Tolerance
NIH · United States
Funds one network running clinical trials and mechanism studies on training the immune system into tolerance for transplants and autoimmune disease.
Translational Centers Using Microphysiologic Systems for Infectious Diseases
NIH · United States
Funds translational centers building human microphysiologic systems — engineered tissue platforms — for infectious disease drug and biologic development.
RNomics Technology Enhancement Centers
NIH · United States
Funds centers that take working RNA-analysis technology and push it further, not invent something new from scratch.
Opportunities for Collaborative Research with the NIH Intramural Research Program
NIH · United States
Funds a research project run jointly with an investigator who already works inside NIH's own labs and clinics.
Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes
NIH · United States
Funds a single milestone-driven project combining multiple existing Type 1 diabetes datasets with multimodal AI models.
Accelerating Research and Development of Next Generation Malaria Vaccines Against Malaria - A Model for Mosquito-Borne Diseases
NIH · United States
Funds basic and preclinical research toward more effective malaria vaccines, designed as a model for other mosquito-borne diseases too.
RNomics Molecular Standards
NIH · United States
Funds RNA reference standards so labs can compare results and trust their instruments across the RNomics program.
Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis
NIH · United States
Funds early, high-risk RNA technology not yet proven at scale, developed through two milestone-gated phases.
Bridge2AI Network for AI Health Science
NIH · United States
Funds a network of centers that builds the methods to judge whether biomedical AI can actually be trusted.
A Holistic Approach to Study Non-Addictive Natural Products for Pain Management
NIH · United States
Funds mechanistic research into how non-addictive natural products actually relieve chronic pain, across the whole body.
Limited Competition: The NHGRI Analysis, Visualization, and Informatics Lab-space (AnVIL)
NIH · United States
Funds one renewed operator for AnVIL, the cloud platform holding more than 5 petabytes of genomic data for reproducible research.
Improved Drug Susceptibility Testing (DST) for Mycobacteria
NIH · United States
Funds faster drug-susceptibility tests for tuberculosis and related mycobacterial infections that skip slow culture-based methods.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
NIH · United States
Funds further development and rigorous technical validation of a cancer research technology that has already cleared basic feasibility.
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research
NIH · United States
Funds early proof-of-concept work testing whether a new cancer research tool, assay, platform or instrument is technically feasible at all.
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management
NIH · United States
Funds the ongoing development, dissemination or upkeep of a cancer informatics tool that has already outgrown its prototype stage.
INCLUDE Project: Omics Phenotypes Related to Down Syndrome
NIH · United States
Funds access to genomic and multi-omics processing of Down syndrome biospecimens through NIH's INCLUDE Project, with no direct cash award.
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development
NIH · United States
Funds small-molecule drug candidates from a lab bench through Phase I testing, with NIH's own chemistry and toxicology experts on call.
NIAMS Clinical Trial Implementation Cooperative Agreement
NIH · United States
Funds a two-phase cooperative agreement to prepare for, then run, a clinical trial in arthritis, musculoskeletal or skin disease.